Edgewise Therapeutics
Founded 2017 · 2 known investors
Edgewise Therapeutics develops novel therapeutics for serious cardiovascular muscle diseases, including hypertrophic cardiomyopathy (HCM) and heart failure. The company focuses on drug development targeting cardiac muscle for patients with life-limiting cardiovascular conditions.
BiotechDigital Health
Investors · 2
Founder mafia
2 people who came through Edgewise Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Edgewise Therapeutics do?
- Edgewise Therapeutics develops novel therapeutics for serious cardiovascular muscle diseases, including hypertrophic cardiomyopathy (HCM) and heart failure. The company focuses on drug development targeting cardiac muscle for patients with life-limiting cardiovascular conditions.
- Who are Edgewise Therapeutics's investors?
- Edgewise Therapeutics's investors include OrbiMed, US Venture Partners.